Protecting the nerve terminals

by Jonathan D Glass
Published 2018-03-01

Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro

by Terrell E. Brotherton, Yingjie Li, Jonathan D. Glass
Published 2013-01-01

The Gene for Slow Wallerian Degeneration (Wlds) Is Also Protective against Vincristine Neuropathy

by Min-Sheng Wang, Yue Wu, Deborah G. Culver, Jonathan D. Glass
Published 2001-02-01

The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry.

by Thomas S Wingo, David J Cutler, Nicole Yarab, Crystal M Kelly, Jonathan D Glass
Published 2011-01-01

The gut microbiome and neuroinflammation in amyotrophic lateral sclerosis? Emerging clinical evidence

by Christina N. Fournier, Madelyn Houser, Malú G. Tansey, Jonathan D. Glass, Vicki Stover Hertzberg
Published 2020-02-01

Validation of machine learning models to detect amyloid pathologies across institutions

by Juan C. Vizcarra, Marla Gearing, Michael J. Keiser, Jonathan D. Glass, Brittany N. Dugger, David A. Gutman
Published 2020-04-01

A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

by Mfon E Umoh, Eric B Dammer, Jingting Dai, Duc M Duong, James J Lah, Allan I Levey, Marla Gearing, Jonathan D Glass, Nicholas T Seyfried
Published 2018-01-01

The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse

by Lindsey R. Fischer, Deborah G. Culver, Albert A. Davis, Philip Tennant, Minsheng Wang, Michael Coleman, Seneshaw Asress, Robert Adalbert, Guillermo M. Alexander, Jonathan D. Glass
Published 2005-06-01

Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients

by Csaba Konrad, Hibiki Kawamata, Kirsten G. Bredvik, Andrea J. Arreguin, Steven A. Cajamarca, Jonathan C. Hupf, John M. Ravits, Timothy M. Miller, Nicholas J. Maragakis, Chadwick M. Hales, Jonathan D. Glass, Steven Gross, Hiroshi Mitsumoto, Giovanni Manfredi
Published 2017-10-01

Longitudinal biomarkers in amyotrophic lateral sclerosis

by Fen Huang, Yuda Zhu, Jennifer Hsiao‐Nakamoto, Xinyan Tang, Jason C. Dugas, Miriam Moscovitch‐Lopatin, Jonathan D. Glass, Robert H. Brown Jr, Shafeeq S. Ladha, David Lacomis, Jeffrey M. Harris, Kimberly Scearce‐Levie, Carole Ho, Robert Bowser, James D. Berry
Published 2020-07-01

CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

by Kelly L. Williams, Simon Topp, Shu Yang, Bradley Smith, Jennifer A. Fifita, Sadaf T. Warraich, Katharine Y. Zhang, Natalie Farrawell, Caroline Vance, Xun Hu, Alessandra Chesi, Claire S. Leblond, Albert Lee, Stephanie L. Rayner, Vinod Sundaramoorthy, Carol Dobson-Stone, Mark P. Molloy, Marka van Blitterswijk, Dennis W. Dickson, Ronald C. Petersen, Neill R. Graff-Radford, Bradley F. Boeve, Melissa E. Murray, Cyril Pottier, Emily Don, Claire Winnick, Emily P. McCann, Alison Hogan, Hussein Daoud, Annie Levert, Patrick A. Dion, Jun Mitsui, Hiroyuki Ishiura, Yuji Takahashi, Jun Goto, Jason Kost, Cinzia Gellera, Athina Soragia Gkazi, Jack Miller, Joanne Stockton, William S. Brooks, Karyn Boundy, Meraida Polak, José Luis Muñoz-Blanco, Jesús Esteban-Pérez, Alberto Rábano, Orla Hardiman, Karen E. Morrison, Nicola Ticozzi, Vincenzo Silani, Jacqueline de Belleroche, Jonathan D. Glass, John B. J. Kwok, Gilles J. Guillemin, Roger S. Chung, Shoji Tsuji, Robert H. Brown, Alberto García-Redondo, Rosa Rademakers, John E. Landers, Aaron D. Gitler, Guy A. Rouleau, Nicholas J. Cole, Justin J. Yerbury, Julie D. Atkin, Christopher E. Shaw, Garth A. Nicholson, Ian P. Blair
Published 2016-04-01